BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29307989)

  • 1. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
    Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
    World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing.
    Armengol G; Sarhadi VK; Ghanbari R; Doghaei-Moghaddam M; Ansari R; Sotoudeh M; Puolakkainen P; Kokkola A; Malekzadeh R; Knuutila S
    J Mol Diagn; 2016 Jul; 18(4):471-9. PubMed ID: 27155048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
    He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
    World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients.
    Saberi F; Youssef O; Kokkola A; Khodadoostan M; Puolakkainen P; Salehi R; Knuutila S
    J Res Med Sci; 2024; 29():4. PubMed ID: 38524743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
    Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
    Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
    Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
    J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
    Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
    Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot spot mutations in Finnish non-small cell lung cancers.
    Mäki-Nevala S; Sarhadi VK; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuuttila A; Knuutila S
    Lung Cancer; 2016 Sep; 99():102-10. PubMed ID: 27565922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencing.
    Zhang L; Chen L; Sah S; Latham GJ; Patel R; Song Q; Koeppen H; Tam R; Schleifman E; Mashhedi H; Chalasani S; Fu L; Sumiyoshi T; Raja R; Forrest W; Hampton GM; Lackner MR; Hegde P; Jia S
    Oncologist; 2014 Apr; 19(4):336-43. PubMed ID: 24664487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing.
    Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
    Oncotarget; 2017 Mar; 8(11):18166-18176. PubMed ID: 28199989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction.
    Li W; Qiu T; Guo L; Ying J; Zhou A
    Pathol Res Pract; 2019 Mar; 215(3):483-489. PubMed ID: 30611619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
    Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
    J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
    Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
    Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
    Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
    Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting colorectal cancer in stool with the use of multiple genetic targets.
    Dong SM; Traverso G; Johnson C; Geng L; Favis R; Boynton K; Hibi K; Goodman SN; D'Allessio M; Paty P; Hamilton SR; Sidransky D; Barany F; Levin B; Shuber A; Kinzler KW; Vogelstein B; Jen J
    J Natl Cancer Inst; 2001 Jun; 93(11):858-65. PubMed ID: 11390535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.
    Muller KE; Marotti JD; de Abreu FB; Peterson JD; Miller TW; Chamberlin MD; Tsongalis GJ; Tafe LJ
    Exp Mol Pathol; 2016 Jun; 100(3):421-5. PubMed ID: 27095739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
    Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
    Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
    Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
    Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.